• NNIT Q2 2026 revenue fell 4.5% year over year to DKK 441.6 million as customer caution persisted, especially in life sciences.
• EBIT excluding special items slipped to DKK 21.3 million, keeping the margin broadly stable at 4.8%.
• EBIT including special items edged up to DKK 2.8 million; special items narrowed to DKK 18.5 million.
• Free cash flow turned positive to DKK 8 million from a negative level a year earlier.
• Maintained 2026 outlook for single-digit negative constant-currency revenue growth, 4%-7% EBIT margin excluding special items, special items below DKK 83 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NNIT A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608271201OMX_____CNEWS_EN_GNW1001259734_en) on August 27, 2026, and is solely responsible for the information contained therein.